About IMCI Pharmaceuticals
Who We Are?
IMCI is a pharmaceutical company that develops cannabis-based medicines to treat chronic and neuropathic pain indications with a global reach.
IMCI R&D is based in Israel with its primary operations being conducted in Europe and Israel and thereafter intends to expand expanded to other territories around the globe.
IMCI is operating in the high-end of the pharmaceutical supply chain based upon a unique combination between Israeli leading research institutions together with its team members who possess a proven track record with cannabinoids R&D and pain management.
Meeting all the regulatory standards
To become a leading pharmaceutical company, who will develop pharmaceutical and medicinal cannabis-based novel medicines to treat chronic and neuropathic pain in prevalent health conditions at an affordable price.